Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
2'-5'-oligoadenylate synthetase-like protein (OASL) is an interferon-inducible enzyme related to the OAS family, predominantly expressed in response to viral infection via IFN signaling[3][4]. While canonical OAS proteins catalyze the synthesis of 2'-5'-linked oligoadenylates that activate RNase L to degrade viral and cellular RNA, human OASL has lost synthetase activity due to changes in its active site[1][3][4]. Instead, OASL contains ubiquitin-like domains at its C-terminus that allow it to mimic polyubiquitin and bind directly to the RIG-I viral RNA sensor, enhancing RIG-I's capacity to induce type I interferons and restrict RNA virus replication[2][3][4]. In DNA virus infection, OASL can inhibit the DNA sensor cGAS, dampening IFN production[1]. OASL is highly dynamic, being upregulated not only by various viruses but also by intracellular pathogenic bacteria, modulating autophagy and antimicrobial peptide secretion and influencing host-pathogen interactions[1]. Variants and polymorphisms in OASL are associated with susceptibility to several viral diseases[3]. There is no evidence of small molecule drugs directly targeting OASL, though its regulation by interferons is therapeutically relevant[4]. OASL is a promising target for modulating innate immunity but poses complexities due to its context-dependent pro- and anti-viral effects[1][2][3][4][5].
For its biological role: Acts as a viral RNA sensor co-factor, enhancing RIG-I-mediated interferon response (by mimicking polyubiquitin). Binds to cytosolic DNA sensor cGAS, inhibiting its activity and interferon signaling (pro-viral role in some DNA virus infections). Upregulated by interferons via IRF3 signaling. Involved in OAS/RNase L pathway activation in avian species.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 2'-5'-oligoadenylate synthetase-like protein (OASL).